- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
VRIO Analysis of Pharmaceutical Industry Challenges in the New Century
Posted by Zachary Edwards on Mar-22-2018
The VRIO Analysis of Pharmaceutical Industry Challenges in the New Century will look at each of its internal resources one by one to assess whether these provide sustained competitive advantage. The Pharmaceutical Industry Challenges in the New Century VRIO Analysis also mentions at each stage whether these resources could be improved to provide a greater competitive advantage. Lastly, the resources analysed are summarised as to whether they offer sustained competitive advantage, has an unused competitive advantage, temporary competitive advantage, competitive parity or competitive disadvantage.
Valuable
- The Pharmaceutical Industry Challenges in the New Century VRIO Analysis shows that the financial resources of Pharmaceutical Industry Challenges in the New Century are highly valuable as these help in investing into external opportunities that arise. These also help Pharmaceutical Industry Challenges in the New Century in combating external threats.
- According to the VRIO Analysis of Pharmaceutical Industry Challenges in the New Century, its local food products are a valuable resource as these are highly differentiated. This makes the perceived value for these by customers high. These are also valued more than the competition by customers due to the differentiation in these products.
- The Pharmaceutical Industry Challenges in the New Century VRIO Analysis shows that Pharmaceutical Industry Challenges in the New Century's employees are a valuable resource to the firm. A significant portion of the workforce is highly trained, and this leads to more productive output for the organisation. The employees are also loyal, and retention levels for the organisation are high. All of this translates into greater value for the end consumers of Pharmaceutical Industry Challenges in the New Century's products.
- According to the VRIO Analysis of Pharmaceutical Industry Challenges in the New Century, its patents are a valuable resource as these allow the firm to sell its products without competitive interference. This results in greater revenue for Pharmaceutical Industry Challenges in the New Century. These patents also provide Pharmaceutical Industry Challenges in the New Century with licensing revenue when it licenses these patents out to other manufacturers.
- The Pharmaceutical Industry Challenges in the New Century VRIO Analysis shows that Pharmaceutical Industry Challenges in the New Century’s distribution network is a valuable resource. This helps it in reaching out to more and more customers. This ensures greater revenues for Pharmaceutical Industry Challenges in the New Century. It also ensures that promotion activities translate into sales as the products are easily available.
- According to the VRIO Analysis of Pharmaceutical Industry Challenges in the New Century, its cost structure is not a valuable resource. This is because the methods of production lead to greater costs than that of competition, which affects the overall profits of the firm. Therefore, its cost structure is a competitive disadvantage that needs to be worked on.
- The Pharmaceutical Industry Challenges in the New Century VRIO Analysis shows that the research and development at Pharmaceutical Industry Challenges in the New Century is not a valuable resource. This is because research and development are costing more than the benefits it provides in the form of innovation. There have been very few innovative features and breakthrough products in the past few years. Therefore, research and development are a competitive disadvantage for Pharmaceutical Industry Challenges in the New Century. It is recommended that the research and development teams are improved, and costs are cut for these.
Rare
- The financial resources of Pharmaceutical Industry Challenges in the New Century are found to be rare according to the VRIO Analysis of Pharmaceutical Industry Challenges in the New Century. Strong financial resources are only possessed by a few companies in the industry.
- The local food products are found to be not rare as identified by Pharmaceutical Industry Challenges in the New Century VRIO Analysis. These are easily provided in the market by other competitors. This means that competitors can use these resources in the same way as Pharmaceutical Industry Challenges in the New Century and inhibit competitive advantage. This means that the local food products result in competitive parity for Pharmaceutical Industry Challenges in the New Century. As this resource is valuable, Pharmaceutical Industry Challenges in the New Century can still make use of this resource.
- The employees of Pharmaceutical Industry Challenges in the New Century are a rare resource as identified by the VRIO Analysis of Pharmaceutical Industry Challenges in the New Century. These employees are highly trained and skilled, which is not the case with employees in other firms. The better compensation and work environment ensure that these employees do not leave for other firms.
- The patents of Pharmaceutical Industry Challenges in the New Century are a rare resource as identified by the Pharmaceutical Industry Challenges in the New Century VRIO Analysis. These patents are not easily available and are not possessed by competitors. This allows Pharmaceutical Industry Challenges in the New Century to use them without interference from the competition.
- The distribution network of Pharmaceutical Industry Challenges in the New Century is a rare resource as identified by the VRIO Analysis of Pharmaceutical Industry Challenges in the New Century. This is because competitors would require a lot of investment and time to come up with a better distribution network than that of Pharmaceutical Industry Challenges in the New Century. These are also possessed by very few firms in the industry.
Imitable
- The financial resources of Pharmaceutical Industry Challenges in the New Century are costly to imitate as identified by the Pharmaceutical Industry Challenges in the New Century VRIO Analysis. These resources have been acquired by the company through prolonged profits over the years. New entrants and competitors would require similar profits for a long period of time to accumulate these amounts of financial resources.
- The local food products are not that costly to imitate as identified by the VRIO Analysis of Pharmaceutical Industry Challenges in the New Century. These can be acquired by competitors as well if they invest a significant amount in research and development. These also do not require years long experience. Therefore, the local food products by Pharmaceutical Industry Challenges in the New Century provide it with a temporary competitive advantage that competitors can too acquire in the long run.
- The employees of Pharmaceutical Industry Challenges in the New Century are also not costly to imitate as identified by the Pharmaceutical Industry Challenges in the New Century VRIO Analysis. This is because other firms can also train their employees to improve their skills. These companies can also hire employees from Pharmaceutical Industry Challenges in the New Century by offering better compensation packages, work environment, benefits, growth opportunities etc. This makes the employees of Pharmaceutical Industry Challenges in the New Century a resource that provides a temporary competitive advantage. Competition can acquire these in the future.
- The patents of Pharmaceutical Industry Challenges in the New Century are very difficult to imitate as identified by the VRIO Analysis of Pharmaceutical Industry Challenges in the New Century. This is because it is not legally allowed to imitate a patented product. Similar resources to be developed and getting a patent for them is also a costly process.
- The distribution network of Pharmaceutical Industry Challenges in the New Century is also very costly to imitate by competition as identified by the Pharmaceutical Industry Challenges in the New Century VRIO Analysis. This has been developed over the years gradually by Pharmaceutical Industry Challenges in the New Century. Competitors would have to invest a significant amount if they are to imitate a similar distribution system.
Organisation
- The financial resources of Pharmaceutical Industry Challenges in the New Century are organised to capture value as identified by the VRIO Analysis of Pharmaceutical Industry Challenges in the New Century. These resources are used strategically to invest in the right places; making use of opportunities and combatting threats. Therefore, these resources prove to be a source of sustained competitive advantage for Pharmaceutical Industry Challenges in the New Century.
- The Patents of Pharmaceutical Industry Challenges in the New Century are not well organised as identified by the Pharmaceutical Industry Challenges in the New Century VRIO Analysis. This means that the organisation is not using these patents to their full potential. An unused competitive advantage exists that can be changed into a sustainable competitive advantage if Pharmaceutical Industry Challenges in the New Century starts selling patented products before the patents expire.
- The distribution network of Pharmaceutical Industry Challenges in the New Century is organised as identified by the VRIO Analysis of Pharmaceutical Industry Challenges in the New Century. Pharmaceutical Industry Challenges in the New Century uses this network to reach out to its customers by ensuring that products are available on all of its outlets. Therefore, these resources prove to be a source of sustained competitive advantage for Pharmaceutical Industry Challenges in the New Century.
From the VRIO Analysis of Pharmaceutical Industry Challenges in the New Century, it was identified that the financial resources and distribution network provide a sustained competitive advantage. The patents are a source of unused competitive advantage. There exists a temporary competitive advantage for employees. There exists a competitive parity for local food products. Lastly, the cost structure of Pharmaceutical Industry Challenges in the New Century is a competitive disadvantage. Research and Development is also a competitive disadvantage.
Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here.
George Frank
5.0
I have the need for a service that perfectly composes the paper. This company provides the assignment in the right manner but the topic was extensive and difficult at this time. Happy to tell you guys that it didn't disappoint me at this time too.
Rosiah Jackson
5.0
Thumbs up! Feeling happy on the grounds of the result is good. Really, all my confusing chapters were resolved from the expert of this service within two weeks.
Jayden Theodore
5.0
I'll keep in touch with this corporation for a research paper. Timely delivery with affordable prices. Thank you!
Sofia James
5.0
All questions were resolved accurately and promptly and this custom paper writing help is helpful. Thank you for the amazing assistance!
Next Articles
- StreamLine The ABC Of A Merger (A): Story Of The Merger Vrio Analysis
- StreamLine The ABC Of A Merger (B): Building The New Organization Vrio Analysis
- StreamLine The ABC Of A Merger (C): The Bumpy Road Of Transformation Vrio Analysis
- Innovating Our Way To The Next Industrial Revolution Vrio Analysis
- Detours In The Path Toward Strategic Information Systems Alignment Vrio Analysis
- Triangle Community Foundation Vrio Analysis
- Strategy Execution Module 10: Using The Job Design Optimization Tool To Build Effective Organizations Vrio Analysis
- Strategy Execution Module 15: Using The Levers Of Control To Implement Strategy Vrio Analysis
- Strategy Execution Module 11: Using Diagnostic And Interactive Control Systems Vrio Analysis
- Dynamic Capabilities And Organizational Agility: Risk, Uncertainty, And Strategy In The Innovation Economy Vrio Analysis
Previous Articles
- Bertelsmann AG Vrio Analysis
- Urban Homesteading Assistance Board Vrio Analysis
- Limits Of Structural Change Vrio Analysis
- Neighborhood Conservation Services Of Barberton: Responding To Change In The Magic City Vrio Analysis
- Samsung And Daewoo: Two Tales Of One City Vrio Analysis
- Rank Xerox : The Success Of Telesales (C), Condensed Vrio Analysis
- Rank Xerox : The Success Of Telesales (C) Vrio Analysis
- Rank Xerox : Is "Telemarketing" The Answer?, Condensed Vrio Analysis
- Rank Xerox : Is "Telemarketing" The Answer? (B) Vrio Analysis
- Rank Xerox : Global Transfer Of Best Practices (A), Condensed Vrio Analysis
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.
Our Guarantees
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!